FEATURED TRIALS

All clinical trials are reviewed by an Institutional Review Board (IRB) to protect the rights and safety of people who join. But some trials stand out because they’re doing more for patients. Our review committee of patients and researchers helped identify some trials that are going above and beyond. They are our featured trials.

Researchers

Do you want your clinical trial to be featured here on our website?

Patients & Caregivers

Do you have questions about or want to participate in a featured trial?

A drug, SER-155, to reduce the risk of infection and graft-versus-host disease (GVHD) after allogeneic (cells from a donor) blood or marrow transplant (BMT)
To find out if SER-155 is safe and works well to reduce infection and GVHD after allogeneic BMT
Allogeneic (cells from a donor) blood or marrow transplant (BMT) or immunosuppressive therapy to treat severe aplastic anemia (SAA) that has not yet been treated in children, teens and young adults
To find out whether allogeneic BMT or immunosuppressive therapy is more effective in treatment of SAA that has not yet been treated in children, teens and young adults
Two drugs, isatuximab and lenalidomide, to treat multiple myeloma that doctors consider high-risk after autologous (your own cells) blood or marrow transplant (BMT)
To find out if the combination of isatuximab and lenalidomide is safe and works well to treat multiple myeloma that doctors consider high-risk after autologous BMT